Effects of angiotensin-converting enzyme inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease

Japanese Journal of Pharmacology

Volumn 83, Issue 1, 2000, Pages 56-62

  Teramoto, Shinji ^a,e   Suzuki, Masashi ^b   Matsuse, Takeshi ^c   Ishii, Takeo ^b   Fukuchi, Yoshinosuke ^d   Ouchi, Yasuyoshi ^b  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e San no Hospital   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Bronchoalveolar lavage; Chemiluminescence; Chronic obstructive pulmonary disease; Oxygen radical

Indexed keywords

ALACEPRIL; AMBROXOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; BRONCHOALVEOLAR LAVAGE FLUID; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; TETRADECANOYLPHORBOL ACETATE;

EID: 0034081286     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.83.56     Document Type: Article

References (37)

1. Schmidt AM, Yan SD, Wautier JL and Stern D: Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84, 489-497 (1999)
2. Patrono C and FitzGerald GA: Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 17, 2309-2315 (1997)
3. Teramoto S, Tomita T, Matsui H, Ohga E, Matsuse T and Ouchi Y: Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: protective roles of glutathione. Jpn J Pharmacol 79, 33-40 (1999)
4. Cluzel M, Damon M, Chanez P, Bousquet J, Crastes De Paulet A, Michel FB and Godard P: Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 80, 195-201 (1987)
5. Kanazawa H, Kurihara N, Hirata K and Takeda T: The role of free radicals in airway obstruction in asthmatic patients. Chest 100, 1319-1322 (1991)
6. Teramoto S, Shu C-Y, Ouchi Y and Fukuchi Y: Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 33, 149-155 (1996)
7. Repine JE, Bast A and Lankhorst I: Oxidative stress in chronic obstructive pulmonary disease, oxidative stress study group. Am J Respir Crit Care Med 156, 341-357 (1997)
8. Rahman I, Morrison D, Donaldson K and MacNee W: Systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154, 1055-1060 (1996)
9. Teramoto S, Suzuki M, Ohga E, Ishii T, Matsusi H, Matsuse T and Ouchi Y: Effects of ambroxol on spontaneous or stimulated reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases. Pharmacology 59, 135-141 (1999)
10. Ondetti MA, Rubin B and Cushman DW: Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196, 441-444 (1977)
11. Williams GH: Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med 319, 1517-1525 (1998)
12. Kleber FX and Wensel R: Current guidelines for the treatment of congestive heart failure. Drugs 51, 89-98 (1996)
13. Glassock RJ: The therapy of idiopathic membranous glomerulonephritis. Semin Nephrol 11, 138-147 (1991)
14. Martin MFR, Surral KE, McKenna F, Dixon JS, Bird HA and Wright V: Captopril: A new treatment for rheumatoid arthritis? Lancet i, 1325-1328 (1984)
15. Gress TW, Nieto FJ, Shahar E, Wofford MR and Brancati E: Hypertension and antihypertensive therapy as risk factor for type 2 diabetes millitus. Atherosclerosis risk in communities study. N Engl J Med 342, 905-912 (2000)
16. Mira ML, Silva MM, Queiroz MJ and Manso CF: Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic Res Commun 19, 173-181 (1993)
17. Lapenna D and Cuccurullo F: Captopril: Does it act as a direct antioxidant by free radical scavenging in humans? Free Radic Biol Med 14, 643-647 (1993)
18. Suzuki S, Sato H, Shimada H, Takashima N and Arakawa M: Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical. Pharmacology 47, 61-65 (1993)
19. Bartosz M, Kedziora J and Bartosz G: Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med 23, 729-735 (1997)
20. Noda Y, Mori A and Packer L: Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol 96, 125-136 (1997)
21. Sekizawa K, Matsui T, Nakagawa T, Nakayama K and Sasaki H: ACE inhibitors and pneumonia. Lancet 352, 1069 (1998)
22. Teramoto S and Ouchi Y: ACE inhibitors and prevention of aspiration pneumonia in elderly hypertensives. Lancet 353, 843 (1999)
23. Teramoto S, Fukuchi Y and Orimo H: Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Chest 103, 1774-1782 (1993)
24. Teramoto S and Fukuchi Y: Improvements in exercise capacity and dyspnoea by inhaled anticholinergic drug in elderly patients with chronic obstructive pulmonary disease. Age Ageing 24, 278-282 (1995)
25. Baldwin E De F, Cournand A and Richards DW Jr: Pulmonary insufficiency: I. physiologic classification, clinical methods of analysis, standard values in normal subjects. Medicine 27, 243-278 (1948)
26. Burrows B, Kasik JE, Niden AH and Barclay WR: Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 84, 789-806 (1961)
27. Teramoto S, Fukuchi Y, Shu CY and Orimo H: Influences of cisplatin combination chemotherapy on oxygen radical generation by blood in elderly and adult patients with lung cancer. Chemotherapy 41, 222-228 (1995)
28. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K and Orimo H: Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur Respir J 8, 450-456 (1995)
29. Teramoto S, Suzuki M, Matsuse T and Ouchi Y: Effect of ambroxol on oxygen radical production and generation by bronchoalveolar lavage cells in young and aged guinea pigs. Jpn J Pharmacol 78, 429-434 (1998)
30. Suzuki M, Teramoto S, Matsuse T, Ohga E, Katayama H, Fukuchi Y and Ouchi Y: Inhibitory effect of ambroxol on superoxide anion production and generation by murine lung alveolar macrophages. J Asthma 35, 267-272 (1998)
31. Teramoto S, Matsuse T, Matsui H, Ohga E, Ishii T, Nagase T and Ouchi Y: Recombinant El-deleted adenoviral vectors induce apoptosis in a rat airway epithelial mucous goblet cell line. Jpn J Pharmacol 81, 73-78 (1999)
32. Ward WF, Molteni A, Ts'ao CH and Hinz JM: Captopril reduces collage and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19, 1405-1409 (1990)
33. Ward WF, Lin PJ, Wong PS, Behnia R and Jalali N: Radiation pneumonitis is rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography. Radiat Res 135, 81-87 (1993)
34. Lusuardi M, Capelli A, Cerutti CG, Spada EL and Donner CF: Airways inflammation in subjects with chronic bronchitis who have never smoked. Thorax 49, 1211-1216 (1994)
35. Wallaert B, Gressier B, Marquette CH, Gosset P, Remy-Jardin M, Mizon T and Tonnel AB: Inactivation of αl-proteinase inhibitor by alveolar infammatory cells from smoking patients with or without emphysema. Am Rev Respir Dis 147, 1537-1543 (1993)
36. Lusuardi M, Capelli A, Caldi S, Spada EL, Spinazzi A and Donner CF: Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest 103, 1783-1791 (1993)
37. Calhoun WJ, Stevens CA and Lambert SB: Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 117, 514-522 (1991)